Evidence map›Paper›PMID 41077617›Full record

ArticleEuropean journal of human genetics : EJHG2026

The LMSz method - an automatable scalable approach to constructing gene-specific growth charts in rare disorders.

Karen J Low, Julia Foreman, Rachel J Hobson, Hannah Kwuo, Elena Martinez-Cayuelas, Berta Almoguera, Purin Marin-Reina, Stefano G Caraffi, Livia Garavelli, Emily Woods and 6 more

Abstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Charting Brain Structure in 22q11.2 Deletion Syndrome with Clinical Neuroimaging.medRxiv : the preprint server for health sciences · 2026
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Karen J LowCentre for Academic Child Health, Bristol Medical School, University of Bristol, Bristol, UK. Karen.low@bristol.ac.uk.ORCID 0000-0002-4975-9363
Julia ForemanEuropean Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.
Rachel J HobsonDDD team, Wellcome Sanger Institute, Hinxton, Cambridge, UK.ORCID 0000-0003-1997-9557
Hannah KwuoCentre for Academic Child Health, Bristol Medical School, University of Bristol, Bristol, UK.
Elena Martinez-CayuelasDepartment of Pediatrics, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain.ORCID 0000-0001-7375-9657
Berta AlmogueraDepartment of Genetics and Genomics, Fundacion Jimenez Diaz University Hospital, Health Research Institute-Fundacion Jimenez Diaz, Universidad Autonoma de Madrid (IIS-FJD UAM), Madrid, Spain.
Purin Marin-ReinaDysmorphology and Neonatology Unit. Hospital Universitari i Politècnic La Fe, Valencia, Spain.ORCID 0000-0003-3780-2077
Stefano G CaraffiMedical Genetics Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.ORCID 0000-0002-5033-7854
Livia GaravelliMedical Genetics Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.ORCID 0000-0002-7684-3982
Emily WoodsDivision of Clinical Medicine, University of Sheffield, Sheffield, UK.ORCID 0000-0003-2349-2688
Meena BalasubramanianDivision of Clinical Medicine, University of Sheffield, Sheffield, UK.
Allan BayatDepartment of Regional Health Research, University of Southern Denmark, Odense, Denmark.ORCID 0000-0003-4986-8006
Charlotte W OckeloenDepartment of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.ORCID 0000-0003-0329-1520
Caroline M WrightDepartment of Human Nutrition, School of Medicine, Dentistry and Nursing, University of Glasgow, Glasgow, UK.ORCID 0000-0001-6256-6315
Helen V FirthEuropean Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.
Tim J ColeUCL Great Ormond Street Institute of Child Health, London, UK.ORCID 0000-0001-5711-8200

Funding

DH | National Institute for Health Research (NIHR) 302303RCUK | Medical Research Council (MRC) MR/V037307/1Wellcome Trust (Wellcome) WT223718/Z/21/Z
6 · The paper itself

Abstract

Children with monogenic neurodevelopmental disorders often grow abnormally. Gene-specific growth charts would be useful but require large samples to construct them using the conventional LMS method. We transformed anthropometry to British 1990 reference z-scores for 328 UK and 264 international individuals with ANKRD11, ARID1B, ASXL3, DDX3X, KMT2A, or SATB2-related disorders, and modelled mean and standard deviation (SD) of the z-scores as gene-specific linear age trends adjusted for sex. Assuming the same skewness in the reference and rare disease distributions, we then back-transformed the mean ±2 SD lines to give gene-specific median, 2nd, and 98th centiles. The resulting z-score charts look plausible on several counts. Only KMT2A shows a (rising) age trend in median height, while BMI and weight increase for several genes, possibly reflecting population trends. Apart from SATB2 and DDX3X, the gene-specific medians are all below the reference (range 0.1th centile for height KMT2A to 36th centile for BMI ANKRD11). Median OFC z-score shows no age trend, with medians ranging from 10th to 30th centile, and ASXL3 is lowest, on the 3rd centile. In 19/24 cases, the centiles for the two sexes are the same on the z-score scale. Our LMSz method produces gene-specific growth charts for rare diseases, which, when used in the correct context, could be an important clinical tool. We plan to automate it within the DECIPHER platform, enabling availability for relevant genes.

Indexed as

Growth ChartsRare DiseasesAdolescentBody HeightChildChild, PreschoolDEAD-box RNA HelicasesDNA-Binding ProteinsFemaleHistone-Lysine N-MethyltransferaseHumansInfantMaleMatrix Attachment Region Binding ProteinsMyeloid-Lymphoid Leukemia ProteinRepressor ProteinsARID1B protein, humanDDX3X protein, humanDEAD-box RNA HelicasesDNA-Binding ProteinsHistone-Lysine N-MethyltransferaseKMT2A protein, humanMatrix Attachment Region Binding ProteinsMyeloid-Lymphoid Leukemia ProteinRepressor ProteinsSATB2 protein, humanTranscription Factors

Identifiers

PMID41077617
PMCPMC12963436

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.